Healthcare

T-Cell Immunotherapy Market Size to Reach USD 26.53 Billion by 2034, Racing Ahead on Cellular Engineering and AI Breakthroughs

Press Release, Healthcare
/ /

Empowering Next-Generation Cancer Treatments with AI and Allogeneic Therapies The global T-cell immunotherapy market is estimated to soar from $8.43 billion in 2025 to approximately $26.53 billion by 2034, driven by a robust CAGR of 13.59% over the forecast period. This growth is propelled by an escalating prevalence of cancer, rapid advances in cellular engineering, […]

Lyophilized Oncology Drug Market to Reach Robust Growth by 2034, Driven by Innovation and Biologic Therapies

Healthcare
/ /

The global lyophilized oncology drug market is poised for substantial growth, fueled by rising cancer incidence and increasing adoption of biologic therapies that require enhanced stability and extended shelf life. Forecasted to grow steadily at a notable compound annual growth rate (CAGR) from 2025 to 2034, lyophilized formulations are becoming essential for preserving the potency

Preeclampsia Diagnostics Market Size to Cross USD 1.70 Billion by 2034

Healthcare
/ /

The global preeclampsia diagnostics market is projected to grow from USD 1.29 billion in 2025 to USD 1.70 billion by 2034, expanding at a CAGR of 3.10%. This robust growth is fueled by increasing maternal health awareness, advances in point-of-care diagnostic technologies, and expanding prenatal screening initiatives worldwide. Preeclampsia Diagnostics Market Key Insights The market

Neoantigen Cancer Vaccine Market Size to Soar USD 1,799.21 Million by 2034

Healthcare
/ /

The global neoantigen cancer vaccine market was valued at USD 475.68 million in 2025 and is forecasted to escalate impressively to approximately USD 1,799.21 million by 2034, representing a compounded annual growth rate (CAGR) of 15.93% from 2025 to 2034. This promising growth is driven by the rising global burden of cancer, increased government investments

Bispecific Antibodies CDMO Market Surges with AI-Driven Innovation to Reach New Heights by 2034

Healthcare
/ /

A robust CAGR and growing demand for targeted therapies set stage for transformative growth of bispecific antibody contract development and manufacturing across global markets The global bispecific antibodies Contract Development and Manufacturing Organization (CDMO) market is projected to witness significant growth from 2025 to 2034, fueled by the rising demand for precision-targeted cancer and autoimmune

Preeclampsia Diagnostics Market Size to Reach USD 1.70 Billion by 2034, Driven by Technological Innovation and Rising Maternal Health Awareness

Healthcare, Press Release
/ /

The global preeclampsia diagnostics market, valued at USD 1.29 billion in 2025, is forecasted to grow steadily to approximately USD 1.70 billion by 2034, registering a CAGR of 3.10%. Accelerated by advancements in diagnostic technologies, widespread prenatal screening, and heightened focus on maternal health, this market displays robust potential to improve pregnancy outcomes worldwide. Preeclampsia

Rapid Expansion in Exosome-Based Cancer Therapy CDMO Market to Reach New Heights by 2034

Healthcare
/ /

The global exosome-based cancer therapy contract development and manufacturing organization (CDMO) market is witnessing rapid growth, propelled by advancements in exosome technology, rising cancer prevalence, and increasing demand for personalized therapies. Expected to grow at a robust CAGR from 2025 to 2034, this market is transforming cancer treatment landscapes with precise drug delivery and innovative

RNA Interference Drug Delivery Market Size to Reach USD 528.60 Billion by 2034 with 18.11% CAGR: Transforming Precision Medicine Through Advanced Silencing Technologies

Healthcare
/ /

The global RNA interference (RNAi) drug delivery market, valued at USD 118.18 billion in 2025, is on a remarkable growth trajectory expected to reach approximately USD 528.60 billion by 2034, expanding at a compound annual growth rate (CAGR) of 18.11%. This robust growth is driven by revolutionary advances in gene silencing technologies and delivery systems,

Checkpoint Inhibitor Biologics CDMO Market Size, Share and Trends 2025 to 2034

Healthcare
/ /

The global checkpoint inhibitor biologics CDMO market is projected to see remarkable growth from 2025 to 2034, driven by rising oncology pipelines, technological advances, and increasing personalized cancer therapies demand. With North America leading and Asia Pacific as the fastest-growing region, the market is expected to witness a dynamic shift in biologics manufacturing processes, incorporating

Oncolytic Virus-Based Gene Therapy Market 2025-2034 | Growth, Trends & Key Players Analysis

Healthcare
/ /

Precision Therapies, AI-Driven Innovations, and Tumor-Targeting Viruses Ignite Growth in Cancer Gene Therapy The global oncolytic virus-based gene therapy market is entering a high-growth era, expanding at an estimated fastest CAGR. This transformative sector is powered by advancements in viral engineering, surging cancer incidence rates, and the rise of combination immunotherapies, supported by regulatory momentum

Scroll to Top